default author photo

Heinz Weidenthaler

Bavarian Nordic GmbH

Germany

  • Bavarian Nordic GmbH

SCHOLARLY PAPERS

2

DOWNLOADS

92

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults

Number of pages: 35 Posted: 12 May 2022
Edgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, Erika Menius, Katrin Nopora, Jane Maclennan and Heinz Weidenthaler
University of Alabama at Birmingham, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic, Inc., Bavarian Nordic GmbH, Bavarian Nordic A/S and Bavarian Nordic GmbH
Downloads 92 (730,864)

Abstract:

Loading...

Vaccine, smallpox, monkeypox, orthopoxvirus, freeze-dried, MVA-BN, modified vaccinia Ankara, lot consistency

2.

Safety and Immunogenicity of Abncov2, a Virus-Like Particle Based Vaccine Against Covid-19 in a Phase 2 Trial in Healthy Adults

16TH VACCINE CONGRESS:P1.30
Posted: 19 Oct 2022
Heinz Weidenthaler, Christine Grigat, Barbara Martin, Laurence DeMoerlooze, Anna Stahl, Erika Menius, Melanie Kolanczyk, Eva Wagner and Darja Schmidt
Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic, Inc., Bavarian Nordic GmbH, Bavarian Nordic GmbH and Bavarian Nordic GmbH

Abstract:

Loading...